These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 11239541

  • 21. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Agrawal R, Prelevic G, Conway GS, Payne NN, Ginsburg J, Jacobs HS.
    Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
    [Abstract] [Full Text] [Related]

  • 22. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Menopause; 1999 Jan; 6(4):299-306. PubMed ID: 10614676
    [Abstract] [Full Text] [Related]

  • 23. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.
    Boyd RA, Zegarac EA, Posvar EL, Flack MR.
    Contraception; 2001 Feb; 63(2):71-6. PubMed ID: 11292470
    [Abstract] [Full Text] [Related]

  • 24. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
    Kotecha PT, Godsland IF, Crook D, Stevenson JC.
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
    [Abstract] [Full Text] [Related]

  • 25. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B, Yildirim B, Demir S, Alatas E.
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
    [Abstract] [Full Text] [Related]

  • 26. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
    Garnero P, Jamin C, Benhamou CL, Pelissier C, Roux C.
    Hum Reprod; 2002 Oct; 17(10):2748-53. PubMed ID: 12351557
    [Abstract] [Full Text] [Related]

  • 27. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [Abstract] [Full Text] [Related]

  • 28. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O, Cacciatore B, Paakkari I, Tikkanen MJ, Viinikka L, Toivonen J.
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [Abstract] [Full Text] [Related]

  • 29. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
    Stanczyk FZ, Chaikittisilpa S, Sriprasert I, Rafatnia A, Nadadur M, Mishell DR.
    Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
    [Abstract] [Full Text] [Related]

  • 30. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 31. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb 10; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 32. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May 10; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 33. Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
    Sieuwerts AM, De Napoli G, van Galen A, Kloosterboer HJ, de Weerd V, Zhang H, Martens JW, Foekens JA, De Geyter C.
    Mol Oncol; 2011 Dec 10; 5(6):504-16. PubMed ID: 21956102
    [Abstract] [Full Text] [Related]

  • 34. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K, Erkkola R, Kaihola HL, Santti R, Irjala K.
    Acta Obstet Gynecol Scand; 1985 Dec 10; 64(8):629-33. PubMed ID: 2938400
    [Abstract] [Full Text] [Related]

  • 35. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA.
    Maturitas; 2000 Feb 15; 34(2):161-8. PubMed ID: 10714911
    [Abstract] [Full Text] [Related]

  • 36. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Feb 15; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 37. Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study.
    Everhov ÅH, Flöter Rådestad A, Nyberg T, Smedby KE, Bergmark K, Lindén Hirschberg A.
    J Sex Med; 2016 Mar 15; 13(3):413-24. PubMed ID: 26843116
    [Abstract] [Full Text] [Related]

  • 38. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
    Mattsson LA, Abrahamsson L, Cullberg G, Samsioe G.
    Arch Gynecol; 1983 Mar 15; 233(2):101-7. PubMed ID: 6683955
    [Abstract] [Full Text] [Related]

  • 39. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb 15; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 40. Plasma oestrogens in postmenopausal women with endometrial cancer.
    Nyholm HC, Nielsen AL, Lyndrup J, Dreisler A, Hagen C, Haug E.
    Br J Obstet Gynaecol; 1993 Dec 15; 100(12):1115-9. PubMed ID: 8297845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.